Are you considering light therapy or curious about the Valeda Light Delivery System for your dry AMD?
The Valeda system received FDA authorization in November 2024 as the first therapy specifically for dry AMD. It uses photobiomodulation — a technology that uses light at three specific wavelengths to improve retinal Show Full Answer
Are you considering light therapy or curious about the Valeda Light Delivery System for your dry AMD?
The Valeda system received FDA authorization in November 2024 as the first therapy specifically for dry AMD. It uses photobiomodulation — a technology that uses light at three specific wavelengths to improve retinal health, reduce inflammation, and enhance visual clarity.
How Treatment Works:
Valeda is administered by eye care professionals in their office. The procedure is straightforward:
- You sit at the device and receive light treatments lasting about 4 minutes per session
- A typical course involves 9 sessions total — 3 sessions per week for 3 to 4 weeks
- No significant side effects were reported in clinical trials
What the Research Showed:
In clinical trials, people who received Valeda treatment experienced significant vision improvement and preservation lasting as long as 24 months. Benefits were particularly strong for those in the early or intermediate stages of AMD.
Researchers also noted a reduction in the number of people who progressed to severe geographic atrophy, where retinal cells break down and cause central vision loss.
Important to Know:
People with more advanced stages of AMD, such as central geographic atrophy or wet AMD, may not experience the same benefits as those with intermediate dry AMD.
If you're interested in Valeda, consider talking with your ophthalmologist about whether it might be appropriate for your specific situation. They can assess your stage of AMD and discuss whether this treatment could help preserve your vision.
November 2, 2025
Continue with Facebook
Continue with Email
Join
Your Privacy Choices
